- Release Date: 15/04/21 10:06
- Summary: Acrux's fourth generic dossier accepted by FDA for review
- Price Sensitive: Yes
- Download Document 241.93KB
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.002(12.5%) |
Mkt cap ! $5.729M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.4¢ | $23.70K | 1.561M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 983379 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 908041 | 2 |
View Market Depth
| Last trade - 16.10pm 13/08/2025 (20 minute delay) ? |
| ACR (ASX) Chart |